Using 3D imaging to improve rectal cancer surgery planning
Part of Cancer, Digestive system clinical trials.
This study tests whether using 3D modeling of your CT and MRI scans helps doctors better detect if rectal cancer is close to the edge of the tissue that needs to be removed during surgery. If you are scheduled for surgery for stage II or III rectal cancer, this could help guide the operation and potentially reduce the chance of cancer left behind.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have rectal cancer that is stage II or III, meaning it has not spread to distant parts of the body.
- You are older than 18 years and your overall health is good enough for surgery and treatment.
- You have not had another cancer or a major medical condition in the last three years that could interfere with the study.
- You have complete medical records, including CT and MRI scans of your rectal area.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special imaging to guide surgery for rectal cancer. It studies whether detailed scans taken before surgery can help doctors remove the cancer more precisely.
This study uses 3D imaging to help doctors plan surgery for locally advanced colon cancer. By creating a detailed model of your tumor and nearby structures, it may help the surgeon remove the cancer more precisely and safely. If you join, you will still receive standard surgery, but the preparation will include this 3D technology.
This study tests an AI system that helps identify cancer or polyp findings during rectal surgery or assessment, using real-time information. It may help surgeons classify tissue more accurately while you are already getting treatment.
This trial uses a special type of MRI scan (called amide proton transfer-weighted imaging) to look at your rectal cancer before and after chemotherapy and/or radiation. The goal is to see if the scan can predict whether the cancer has completely disappeared by the time of surgery, which could help guide future treatment decisions.
This trial tests whether a computer model can help doctors predict how difficult the surgery will be, so they can choose the best surgical approach for removing middle to lower rectal cancer. It aims to make the operation safer and more effective for patients like you.
This study uses an AI computer program to read special MRI images and predict how well treatment (given before surgery) will work for people with locally advanced rectal cancer. It may help doctors better plan who benefits most from neoadjuvant therapy (treatment before surgery).
Hear when a new General Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.